We report a rare case ofextramedullary plasmacytoma of the nasal septum in a 65-year-old woman. She presented with a 2-month history ofleft-sided nasal obstru ction and intermittent blood-tinged nasal crusting. Nasal endoscopy revealed that a dark-red mass had aris en from the nasal septum ; no evidence of invasion to adja cent tissue s was seen. A biopsy specimen was diagnosed as a plasmacytoma (kappa light chain-type) . Serum and urine electrophoresis failed to dete ct any myeloma component or Bence Jones protein. All oth er screening tests to rule out multiple myeloma were negative. These findings confirmed the diagnosis of extramedullary plasmacytoma. The mass was completely removed via an endoscopic approach. No recurrence was noted at the 2-yearfollow-up.
Introduction
Plasmacytomas are malignant tumors of monoclonal plasma celIs. They originate in either bone (solitary osseous plasmacytoma) or in soft tissue (extramedulIary plasmacytoma) .' ExtramedulIary plasmacytoma is a rare localized tumor. It has no characteristics of multiple myeloma, but the development of multiple myeloma has been observed in 8 to 36% of patients."
Nearly 80% of alI extramedulIary plasm acytomas occur in the head and neck; most of these arise in the upper aerodigestive tract , probably because of the abundance of lymphatic tissue in this area.v' ExtramedulIary plasmacytoma represents less than I% of alI head and neck malignancies," and it accounts for 4% of alI nonepithelial tumor s of the nasal cavity, nasopharynx, and paranasal sinuses.' We describe a case of extramedulIary plasmacytoma that arose from the nasal septum.
Case report
A65-year-old woman presented to our clinic with a 2-month history of left-sided nasal obstruction and intermittent blood-tinged nasal crusting. Nasal endo scopy detected a dark-red mass on the nasal septum (figure I). No cervical lymph nodes were palpable.
Computed tomography (CT) of the nasal cavities and paranasal sinuses showed that the mass protruded from the middle part of the septum but did not involve the underlying septal framework (figure 2). Histopathologic examination of a biopsy specimen revealed that the neoplasm exhibited a uniform population of plasma celIs. On immunohistochemistry by the biotin-avidin immunoenzyme technique, these celIs stained positive only for the kappa light chain ( figure 3 ). Based on these findings, we presumptively diagnosed the tumor as a plasmacytoma.
Further clinical examinations were undertaken to look for multiple myeloma. These investigations included a complete blood celI count, measurement of serum calcium and creatinine levels, serum protein electrophoresis and immunoelectrophoresis, urinalysis for Bence Jones protein , evaluation of~2 -microglobulin, a skeletal survey with plain films (skull, ribs, humeri, and femurs), abdominal ultrasonography, bone marrow aspiration, and biopsy. All finding s were within normal limits.Accordingly, we ruled out multiple myeloma and confirmed a final diagnosis of primary extramedullary plasmacytoma of the nasal septum.
The septal mass was completely removed via an endonasal endoscopic approach. The mass was easily stripped from the underlying cartilage and bony portion of the nasal septum. At the 2-year follow -up, the patient exhibited no evidence of recurrence.
Discussion
The Extramedullary plasmacytoma is a rare soft-tissue malignant neoplasm that is made up of monoclonal plasma cells . It can be either primary (without evidence of disease in other foci) or part of a systemic process during the course of multiple myeloma.
The first case of extramedullary plasmacytoma was reported in 1905 by Schridde.? Between then and 1997, more than 400 articles addressing extramedullary plasmacytoma were published." In 1999, Alexiou et al reviewed all previous reports of extramedullary plasmacytoma and found 869 cases; 714 (82.2 %) of them had occurred in the upper aerodigestive tract.' The most frequently affected areas in the upper aerodigestive tract were the nasal cavity or paranasal sinuses (43.8 %), followed by the nasopharynx (18.3 %), the oropharynx (17.8%), and the larynx (11.1%). 4 Extramedullary plasmacytoma is more common in males (ratio: 4 to 1), and 95% of cases occur in patients older than 40 years .10 Extramedullary plasmacytoma of the upper aerodigestive tract usually presents as a submucosal, reddish , sessile or polypoid tumor that is rarely ulcerated. I Most occur as single lesions; 10 to 20 % of cases feature multiple lesions.P
The clinical presentation is primarily a function of the mass effect and varies according to the site of involvement. Because most of these lesions arise in the sinonasal or nasopharyngeal area, the most common symptoms are a nasal mass, nasal obstruction, and epistaxis.II Other reported presenting symptoms include nasal discharge, pain, proptosis, cervical lymphadenopathy, and cranial nerve palsy. 10 The diagnosis of extramedullary plasmacytoma usually follows histologic examination. A diffuse or sheetlike proliferation of plasma cells of varying maturity and atypia is seen. Also, an eccentrically placed nucleus and a perinuclear hof (owing to a prominent Golgi apparatus) can be seen .12 Immunohistochemical staining will demonstrate the monoclonal nature of the plasma cells and confirm the neoplastic nature of the lesion. In addition, immunohistochemical study is used to differentiate extramedullary plasmacytoma from benign reactive plasmacytosis as well as other malignant disorders, such as undifferentiated carcinoma, melanoma, and esthesioneuroblastorna."
When a plasmacytoma is confirmed histologically, secondary diagnostic procedures must be carried out to exclude systemic involvement. This workup may include a complete blood count; measurement of calcium, serum urea nitrogen, and creatinin e level s; serum and urine electrophoresis with immunofixation; a complete skeletal radiographic survey; and a bone marrow biopsy."
Although se veral reports reg ard ing extramedullary plasmacytoma in the nasal cavity have been publi shed , a finding of such a lesion in the nasal septum is quite rare .
Mali gnant tumors of the nasal septum (including extramedullary pla smacytoma) are treated by surgery and/or radiotherapy." Although extramedullary pla smacytom a is known to be radiosen sitive, most authors recommend a combination of surgery and radiotherapy for nasal cavity lesions. 15· 19 The lesion in our patient was localized in the nasal septum, and there was no sign of inva sion into the underlying bone or cart ilage. Th erefore, after we rem oved the tum or (while preserving the septal framework), we did not consider postoperative radiotherapy. 722 Local recurren ce has been repor ted to occ ur in 8 to 30% of adequately treated cases .v? Conversion of extra medullary pla smacytom a to multiple mye loma has been repo rted in 8 to 36% of cases within 3 to 6 1 month s.i-' Th erefore, long-term follow-up, including both local and systemic surveill ance, is necessary. CT and measurement s of serum immu noglobul in and urin ary Bence Jones prote in levels may be useful in detectin g recu rrence or conversion to multiple myeloma.
